ONE — 01 Communique Laboratory Income Statement
0.000.00%
Last trade - 00:00
- CA$3.37m
- CA$3.24m
- CA$0.47m
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.283 | 0.522 | 0.885 | 1.03 | 0.474 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.572 | 1.13 | 1.46 | 1.61 | 1.15 |
Operating Profit | -0.289 | -0.606 | -0.57 | -0.587 | -0.676 |
Net Income Before Taxes | -0.289 | -0.606 | -0.57 | -0.587 | -0.676 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.314 | -0.657 | -0.657 | -0.662 | -0.722 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.314 | -0.657 | -0.657 | -0.662 | -0.722 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.314 | -0.657 | -0.657 | -0.662 | -0.722 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.008 | -0.008 | -0.007 | -0.007 | -0.007 |